An Exploratory Clinical Study of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
An Exploratory Clinical Study of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors	Solid Tumor	Recruiting	Early phase 1	2021-12-21		NCT05166070

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Shanghai IASO Biotechnology Co., Ltd	5
The First Affiliated Hospital with Nanjing Medical University	319

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affiliated Hospital with Nanjing Medical University	Nanjing	China	32

Clinical trials